State

US Virgin Islands product recalls

73,824 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.

What the numbers show

Total: 178
Critical: 12
Severe: 39
Most recent: 2026-10-21

Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.

Which agencies issued them

These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,824 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

54501–54525 of 74002

HighFDA (Drugs)·D-650-2015·2015-04-29
Attix Pharmaceuticals Recalls Epinephrine Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling epinephrine active pharmaceutical ingredient distributed to compounding pharmacies and research organizations due to potential penicillin cross-contamination.
Product
Epinephrine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1488-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects
Wright Medical Technology is recalling 148 units of the Crosscheck Plating system because specific dimensions are out of specification, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, 2mm Step, Left, REF CCP-LPX2L. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-570-2015·2015-04-29
Attix Pharmaceuticals Recalls Celecoxib API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Celecoxib active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-660-2015·2015-04-29
Attix Pharmaceuticals Recalls Ethambutol HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Ethambutol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Ethambutol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1515-2015·2015-04-29
Abbott OptiMedica Catalys Precision Laser System Recalled for Corneal Scoring Risk
Abbott Medical Optics is recalling 202 OptiMedica Catalys Precision Laser Systems because loss of suction during cataract surgery may cause corneal scoring.
Product
OptiMedica Catalys Precision Laser System; Model No(s). Catalys-U (US), and Catalys-I (Outside US). Product Usage: Indicated for use in patients undergoing cataract surgery for removal of crystalline lens.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1470-2015·2015-04-29
Churchill Medical Systems Recalls 4-inch Microbore Trifurcated Extension Sets
Churchill Medical Systems is recalling 2,200 units of 4-inch Microbore Trifurcated Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and female luer.
Product
4" Microbore Trifurcated Ext set, Product Code: BN-308 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-648-2015·2015-04-29
Attix Pharmaceuticals Recalls Enalapril Maleate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Enalapril Maleate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Enalapril Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-884-2015·2015-04-29
Attix Pharmaceuticals Recalls Roflumilast API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Roflumilast active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Food)·F-2018-2015·2015-04-29
Rising Moon Organics Spinach Florentine Ravioli Recalled for Listeria
Carmel Food Group is recalling Rising Moon Organics Spinach Florentine Ravioli because the spinach used in manufacturing was found to contain Listeria monocytogenes.
Product
Rising Moon Organics Spinach Florentine Ravioli; Net Wt 8 oz. (227g) UPC 7 85030 22770 1 Distributed by Rising Moon Organics 313 Iron Horse Way Providence, RI 02908
Category
Food
Distribution
Distributed nationwide
HighFDA (Drugs)·D-630-2015·2015-04-29
Attix Pharmaceuticals Recalls Digoxin Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Digoxin active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Digoxin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-615-2015·2015-04-29
Attix Pharmaceuticals Recalls Daptomycin API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Daptomycin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Daptomycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-847-2015·2015-04-29
Attix Pharmaceuticals Recalls Polidocanol Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Polidocanol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Polidocanol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-894-2015·2015-04-29
Silver Sulfadiazine Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Silver Sulfadiazine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Silver Sulfadiazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-905-2015·2015-04-29
Sucralfate API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling sucralfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sucralfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1489-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects
Wright Medical Technology is recalling 242 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX plate, 2mm Step, Right, REF CCP-LPX2R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-780-2015·2015-04-29
Attix Pharmaceuticals Recalls Metaxalone API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Metaxalone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Metaxalone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1478-2015·2015-04-29
Churchill Medical Systems Recalls 6-inch Trifurcated Sets with Bionectors
Churchill Medical Systems is recalling 1,650 6-inch trifurcated sets with Bionectors due to a potential leak caused by insufficient bonding between the needleless device and the female luer.
Product
6" Trifurcated set with Bionectors, Product Code: BN-944 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-528-2015·2015-04-29
Atovaquone API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Atovaquone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Atovaquone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-618-2015·2015-04-29
Attix Pharmaceuticals Recalls Demecarium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Demecarium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Demecarium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-724-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxyzine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxyzine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hydroxyzine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-688-2015·2015-04-29
Flurbiprofen API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling flurbiprofen active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Flurbiprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1487-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 142 units of the Crosscheck Plating system because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, 1mm Step, Right, REF CCP-LPX1R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-666-2015·2015-04-29
Attix Pharmaceuticals Recalls Etoposide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Etoposide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Etoposide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-585-2015·2015-04-29
Attix Pharmaceuticals Recalls Cilostazol API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling cilostazol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Cilostazol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-561-2015·2015-04-29
Attix Pharmaceuticals Recalls Carbimazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Carbimazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Carbimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide